Psoriasiform eruption induced by captopril and chlorthalidone

Area of Science:

• Dermatology
• Pharmacology

Background:

• Psoriasiform eruptions are inflammatory skin conditions that can be triggered by various factors.
• Drug-induced skin reactions are a significant concern in clinical practice.

Observation:

• Two cases of psoriasiform eruption were observed in patients taking specific medications.
• The eruption appeared to be a direct consequence of captopril and chlorthalidone use.

Findings:

• Captopril and chlorthalidone are identified as potential causative agents for psoriasiform eruptions.
• This expands the known list of drugs capable of inducing such dermatological reactions.

Implications:

• Clinicians should consider captopril and chlorthalidone in the differential diagnosis of psoriasiform drug eruptions.
• Non-beta-adrenergic blocking agents are important to evaluate when suspecting drug-induced psoriasiform eruptions.